Lycazid-M Tablet: A Dual Therapy for Blood Sugar Management

Lycazid-M Tablet is a unique combination medication containing both Gliclazide (80mg) and Metformin (500mg). This dual-action approach offers effective blood sugar control in individuals with Type 2 Diabetes.

Gliclazide, a fast-acting sulfonylurea, stimulates insulin secretion from the pancreas to lower blood glucose levels.
Metformin, an oral biguanide, works by reducing hepatic glucose production and improving insulin sensitivity.

Taken together, these medications provide comprehensive blood sugar control by targeting multiple mechanisms simultaneously. This dual therapy offers:

* Rapid onset of action: Gliclazide quickly reduces blood glucose levels within hours.
* Long-term efficacy: Metformin helps regulate glucose metabolism for sustained effectiveness over time.
* Safety and tolerability: Lycazid-M is generally well-tolerated with minimal side effects.

Consult your healthcare professional before starting this medication, as it may interact with other medications or existing health conditions. This information is not a substitute for professional medical advice.